Ana M. Santander
University of Miami Health System(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Gut microbiota and health, Immune Response and Inflammation, Microscopic Colitis, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis(2020)285 cited
- → Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD(2020)174 cited
- → Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis(2020)127 cited
- → Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians(2016)119 cited
- → Paracrine Interactions between Adipocytes and Tumor Cells Recruit and Modify Macrophages to the Mammary Tumor Microenvironment: The Role of Obesity and Inflammation in Breast Adipose Tissue(2015)109 cited
- → CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus(2017)109 cited
- → Intestinal Epithelial Cells Respond to Chronic Inflammation and Dysbiosis by Synthesizing H2O2(2019)53 cited
- → Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy(2022)26 cited
- → DUOX2 activation drives bacterial translocation and subclinical inflammation in IBD-associated dysbiosis(2025)18 cited
- → Intestinal Epithelial Inactivity of Dual Oxidase 2 Results in Microbiome-Mediated Metabolic Syndrome(2023)13 cited